Efficacy of pharmacist intervention for a patient who takes incretin modulator. - Trial UMIN000050659
Access comprehensive clinical trial information for UMIN000050659 through Pure Global AI's free database. This phase not specified trial is sponsored by Chiba Pharmaceutical Association and is currently Not yet recruiting. The study focuses on Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050659
Not yet recruiting
behavioral
Trial Details
University Hospital Medical Information Network • UMIN000050659
Efficacy of pharmacist intervention for a patient who takes incretin modulator.
Study Focus
Sponsor & Location
Chiba Pharmaceutical Association
Japan
Timeline & Enrollment
N/A
Apr 01, 2023
N/A
ICD-10 Classifications
Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications
Data Source
University Hospital Medical Information Network
UMIN000050659
Non-Device Trial